EP Patent
EP3437645B1 — Film-coated tablet having high chemical stability of active ingredient
Assigned to Intercept Pharmaceuticals Inc · Expires 2021-09-22 · 5y expired
What this patent protects
Patent listed against Orgovyx.
Drugs covered by this patent
- Orgovyx (relugolix) · MYOVANT SCIENCES
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.